Showing results (961-970 of 1,000) with videos related to

Sort By:
Pageof 100
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinaseJames Kempson, Junqing Guo, Jagabandhu Das, et al.
Genes & Development|April 17, 2010
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancerTrudy G Oliver, Kim L Mercer, Leanne C Sayles, et al.
The Journal of Allergy and Clinical Immunology|September 25, 2010
Factors predicting inhaled corticosteroid responsiveness in African American patients with asthmaWendy Gould, Edward L Peterson, Gloria Karungi, et al.
The Journal of Biological Chemistry|March 13, 2015
Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase DomainJohn S Tokarski, Adriana Zupa-Fernandez, Jeffrey A Tredup, et al.
JTCVS Open|April 10, 2026
Ross procedure after prior aortic valve intervention: Outcomes from the North American Ross Consortium databaseCody W Dorton, Taylor Pickering, Kyle A McCullough, et al.
Bioorganic & Medicinal Chemistry Letters|November 20, 2010
Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritisAlaric J Dyckman, Charles M Langevine, Claude Quesnelle, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2014
Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseasesQing Shi, Andrew Tebben, Alaric J Dyckman, et al.
JTCVS Open|May 4, 2026
Short-term and midterm results of a North American multicenter study of the Ross procedure in patients older and younger than 50 years of ageScott C DeRoo, Tsung-Wei Ma, Kyle A McCullough, et al.
Annals of Neurology|June 24, 2008
A novel human disease with abnormal prion protein sensitive to proteasePierluigi Gambetti, Zhiqian Dong, Jue Yuan, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 5, 2009
Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritisKathleen M Gillooly, Mark A Pattoli, Tracy L Taylor, et al.
Pageof 100